Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: BioNTech SE

Market Cap 20.12B 23.32B 18.5B 17.41B 32.72B 2,201B 32.99B 219B 85.34B 1,080B 87.53B 85.66B 3,737B P/E 2026 *
-18.1x
P/E 2027 * -17.8x
Enterprise Value 9.27B 10.74B 8.52B 8.02B 15.07B 1,014B 15.2B 101B 39.31B 498B 40.32B 39.45B 1,721B EV / Sales 2026 *
4.28x
EV / Sales 2027 * 4.86x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day+3.04%
1 week+7.05%
Current month-3.89%
1 month+2.98%
3 months-2.78%
6 months+0.68%
Current year-3.13%
1 week 88.58
Extreme 88.58
93.15
1 month 84.96
Extreme 84.955
97.44
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
464
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2018
Chief Executive Officer 60 02/06/2008
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 55 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
05-12Free

Executive/Senior Manager

22,655 0.0094%
05-12Free

Chief Operating Officer

22,655 0.0094%
05-12Free

Chief Financial Officer

33,982 0.0141%
Change 5-day change 1-year change 3-year change Capi.($)
+3.04%+7.05%-12.15%-18.06% 22.63B
+3.23%+2.25%+65.02%+113.87% 54.54B
+0.04%+1.20%+47.67%+36.75% 43.86B
+3.07%+7.15%-1.82%+392.25% 20.7B
-0.53%+0.54%+16.19%-37.07% 15.84B
+5.27%+1.87%+13.67%-38.81% 14.83B
+0.65%-0.27%+26.80%+174.70% 13.1B
-5.17%+0.50%+21.80% - 12.66B
-0.27%+6.06%+78.78%+104.79% 11.56B
+1.92%+2.43%+112.68%+232.59% 11.68B
Average +1.12%+2.44%+36.86%+106.78% 22.14B
Weighted average by Cap. +1.55%+2.31%+39.01%+98.63%

Financials

2026 *2027 *
Net sales 2.17B 2.51B 1.99B 1.87B 3.52B 237B 3.55B 23.6B 9.19B 116B 9.42B 9.22B 402B 2.23B 2.59B 2.05B 1.93B 3.63B 244B 3.66B 24.3B 9.46B 120B 9.7B 9.5B 414B
Net income -1.05B -1.22B -966M -909M -1.71B -115B -1.72B -11.45B -4.46B -56.42B -4.57B -4.47B -195B -1.17B -1.35B -1.07B -1.01B -1.89B -127B -1.91B -12.7B -4.94B -62.57B -5.07B -4.96B -216B
Net Debt -10.85B -12.58B -9.98B -9.39B -17.65B -1,187B -17.79B -118B -46.03B -583B -47.21B -46.2B -2,016B -9.28B -10.76B -8.53B -8.03B -15.09B -1,015B -15.22B -101B -39.37B -498B -40.38B -39.51B -1,724B
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
17/06/26 92.22 $ +3.04% 901,627
16/06/26 89.50 $ -1.43% 819,247
15/06/26 90.80 $ +0.29% 825,403
12/06/26 90.54 $ +1.12% 1,130,846
11/06/26 89.54 $ +3.93% 3,095,021
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
79.56EUR
Average target price
106.75EUR
Spread / Average Target
+34.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!